The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups-Reference-Cited by-同舟云学术

The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups

Published:2016-08-23 Issue: Volume:6 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Ricco Anthony,Manahan Genevieve,Lanciano Rachelle,Hanlon Alexandra,Yang Jun,Arrigo Stephen,Lamond John,Feng Jing,Mooreville Michael,Garber Bruce,Brady Luther

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference32 articles.

1. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer;Alicikus;Cancer,2011

2. Stereotactic body radiotherapy as treatment for organ confined low and intermediate risk prostate carcinoma, an eight year study;Katz;Radiat Oncol,2014

4. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials;King;Radiother Oncol,2013

5. Patient-reported outcomes in NRG oncology/RTOG 0938, a randomized phase 2 study evaluating 2 ultrahypofractionated regimens (UHRs) for prostate cancer;Lukka;Int J Radiat Oncol Biol Phys,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrafractional motion and dosimetric analysis in prostate stereotactic body radiation therapy with auto beam hold technique;Biomedical Physics & Engineering Express;2024-06-26

2. Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer;Reports of Practical Oncology and Radiotherapy;2021-04-14

3. Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review;Cancers;2021-02-12

4. Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy;Strahlentherapie und Onkologie;2020-06-09

5. Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL);BMJ Open;2020-02